Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy
暂无分享,去创建一个
G. Demetri | J. Baselga | D. Haber | C. Benes | S. George | J. Morgan | D. Harmon | E. Choy | J. Butrynski | A. Wagner | G. Cote | D. D’Adamo | Y. Flamand | Yael Flamand